Quality of life outcomes with sublingual immunotherapy

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 30, Issue 5, 2009, Pages 305-311

  Wise, Sarah K ^a,b   Woody, Jamie ^a   Koepp, Sarah ^a   Schlosser, Rodney J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b EMORY CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

ABSENCE OF SIDE EFFECTS; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; HUMAN; IMMUNOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SKIN TEST; SUBLINGUAL IMMUNOTHERAPY; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; AGED; ALLERGENS; ANTI-ALLERGIC AGENTS; CONJUNCTIVITIS; FEMALE; HUMANS; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69249223070     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2008.06.003     Document Type: Article

References (35)

1. Committee on the Safety of Medicines update: desensitizing vaccines. Br Med J 293 (1986) 948
2. Dunsky E., Goldstein M., Dvorin D., et al. Anaphylaxis to sublingual immunotherapy. Allergy 61 (2006) 1235
3. Passalacqua G., Guerra L., Pasquali M., et al. Non-injection routes for allergen immunotherapy: focus on sublingual immunotherapy. Inflammation Allergy Drug Target 5 (2006) 43-51
4. Antico A., Pagani M., and Crema A. Anaphylaxis by latex sublingual immunotherapy. Allergy 61 (2006) 1236-1237
5. Bousquet J., Lockey R., and Malling H. World Health Organization position paper-allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy 53 Suppl 48 (1998) S5-S16
6. Malling H., Abreu-Norguera J., Alvarez-Cuesta E., et al. EAACI/ESPAI position paper on local immunotherapy. Allergy 53 (1998) 833-844
7. Bernardis P., Agnoletto M., and Puuccinelli P. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Investig Allergol Clin Immunol 6 (1996) 55-62
8. Mungan D., Misirligil Z., and Gurbuz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma: a placebo controlled study. Ann Allergy Asthma Immunol 82 (1999) 485-490
9. Quirino T., Iemoli E., and Siciliani E. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy 26 (1996) 1253-1261
10. Krouse J., and Mabry R. Skin testing for inhalant allergy 2003: current strategies. Otolaryngol Head Neck Surg 129 (2003) S33-S49
11. Bent J., and Kuhn F. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 111 (1994) 580-588
12. Juniper E., Thompson A., Ferrie P., et al. Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 30 (2000) 132-140
13. Dahl R., Kapp A., Colombo G., et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 118 (2006) 434-440
14. Durham S., Yang W., Pedersen M., et al. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117 (2006) 802-809
15. Wilson D., Lima M., and Durham S. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60 (2005) 4-12
16. Valovirta E., Jacobsen L., Ljorring C., et al. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 61 (2006) 1177-1183
17. Rolinck-Werninghaus C., Wolf H., Liebke C., et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 59 (2004) 1285-1293
18. Penagos M., Compalati E., Tarantini F., et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 97 (2006) 141-148
19. Marogna M., Spadolini I., Massolo A., et al. Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol 115 (2005) 1184-1188
20. Lue K., Lin Y., Sun H., et al. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol 17 (2006) 408-415
21. Bahceciler N., Isik U., Barlan I., et al. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmon 32 (2001) 49-55
22. Calamita Z., Saconato H., Pela A., et al. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized clinical trials using the Cochrane Collaboration method. Allergy 61 (2006) 1162-1172
23. Di Rienzo V., Marcucci F., Puccinelli P., et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 33 (2003) 206-210
24. Bousquet J., and van Cauwenberge P. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108 Suppl 5 (2001) S240-S245
25. Akdis M., Blaser K., and Akdis C. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 116 (2005) 961-968
26. Moingeon P., Batard T., Fadel R., et al. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 61 (2006) 151-165
27. Cox L., Linnemann D., Nolte H., et al. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol 117 (2006) 1021-1035
28. Malling H., Lund L., Ipsen H., et al. Safety and Immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets. J Investig Allergol Clin Immunol 16 (2006) 162-168
29. Andre C., Perrin-Fayolle M., Grosclaude M., et al. A double-blind placebo-controlled evaluation of sublingual immunotherapy with a standard ragweed extract in patients with seasonal rhinitis. Int Arch Allergy Immunol 131 (2003) 111-118
30. Ciprandi G., Fenoglio D., Cirillo I., et al. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 95 (2005) 38-44
31. Cosmi L., Santarlasci V., Angeli R., et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen specific immunoglobulin E and increases both interferon-gamma and interleukin-10 production. Clin Exp Allergy 36 (2006) 261-272
32. Marcucci F., Sensi L., and Frati F. Sublingual tryptase and ECP in children treated with grass pollen sublingual immunotherapy (SLIT): safety and immunologic implications. Allergy 56 (2001) 1091-1095
33. Marcucci F., Sensi L., di Cara G., et al. Dose dependence of immunological response to sublingual immunotherapy. Allergy 60 (2005) 952-956
34. Larsen T., Poulsen L., Melac M., et al. Safety and tolerability of grass pollen tablets in sublingual immunotherapy: a phase 1 study. Allergy 61 (2006) 1173-1176
35. Gidaro G., Marcucci F., Sensi L., et al. The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy 35 (2005) 565-571